Reddit Posts
Trump just signed an EO to fast-track psychedelics. ATAI ($1.4B) and GHRS ($1.04B) are Phase 3-ready with FDA Breakthrough designations.
📊 Updated Google Sheets stock watchlist (3,000+ companies, live data)
A neuroscientist's prediction: GHRS will go to the moon
I went all in with 7 SOL – not much, but it’s all I had
Golden Hunter Resources (CSE: $HUNT). The Strongest Land Package I've Ever Seen
Golden Hunter Resources (CSE: $HUNT). The Strongest Land Package I've Ever Seen
Guardant Health (GH) Presents Data Demonstrating Strong Performance of Shield Multi-Cancer Detection Test Across 10 Tumor Types
Domestic Manufacturing Push - Will Policy Shifts Favor Innovative Diagnostics Like $MYNZ, $GH, $EXAS?
BioNTech's mRNA Cancer Push – Is It a Wake-Up Call for $MYNZ, $EXAS & $GH?
Nasdaq $MYNZ up 8.4% now - what's happening and why:
Nasdaq $MYNZ up 8.4% now - what's happening and why:
Forget the Hype — This Company Has a Real Product in the Market
Can THIS Outperform Big Names (EXAS GH) in Early Cancer Detection?
GD*HG: Ready to take off? 30 sec to the MOON!
Bearish $GHRS FDA Clinical Hold GH Research Provides Updates and Guidance on its Clinical Development Program for GH001
WiMi Hologram Cloud (WIMI) developed its AI computing technology
AIGC Brings The Productivity: The development trend of WIMI become more distinct
Nvidia stock breaks out, flashing bullish sign, with earnings due — Is it a buy?
Nvidia earnings to offer first true glimpse of the AI windfall
Wall Street analysts expect Nvidia stock ($NVDA) to surge 25%; are they underestimating?
BTBT is the Most Viable Cheap Public Mining Company
A 23-Year-Old Man Flees With His Father's GH 9,500 And Leaves This Behind (See Details)
Glass House Brands Closes Morro Bay Natural Healing Center Dispensary Acquisition 09/15/2022 $GLASF
$BTCM Why is Bit Mining moving today? As $ETH.X is hitting $2,000 this week, Bit Mining is ether focused, it mines 25,000 ether per year, 4.8 GH/s modern facility. Has 82.5MW bitcoin facility in Ohio and is Top 10 World Mining Pool business. It Acquired Microchip Producer in May 2022. PT $2
Ethereum ripping back to $2,000 - check and load $BTCM early before others
$BTCM As $ETH.X is gaining momentum and has doubled last weeks, Bit Mining is a blockchain stock to watch. In addition to $BTC.X , it has 4,800 GH/s Ethereum mining capacity in Hong Kong. Company in addition to mining it produces chips. Worth looking!
$BTCM Free float 57m, SP .72 - Check this one guys, this looks ready to squeeze.
$GLASF Glass House brands Inc. Completes Acquisition....
UCB to acquire Zogenix $ZGNX for $1.9 billion, Bright Minds Biosciences' ($DRUG )BMB-101 for the same indication to hit clinical trials in a couple of months
Sleeping on anti-aging labs can cause you to die younger and broke.
Sleeping on anti-aging labs can cause you to die younger and broke.
Sleeping on anti-aging labs can cause you to die younger and broke.
Powerbridge Technologies Establishes Cryptocurrency Mining Fleets for Bitcoin and Ethereum in Hong Kong $PBTS
SOS Announces Completion of Phase I of Leibodong Mine and Receipt of 575 ETH Mining Rigs
$AEZS Aeterna Zentaris Potential to Move Higher (Currently 1.55) (DD)
Mentions
It offers zero discount and a poorer experience over using the models directly like Claude, Codex etc, it doesn’t have as wide a range of models available as its competitor harnesses, it has shockingly poor rate limits that make it unusable. Nobody who needs a coding agent experience would choose GH Copilot.
If you don’t recognize that GH is a scam then you lack more than good faith.
I don't expect their Q2 costs to get back to pre-raid levels. And I wasn't ranting, I was stating stating a fact that their cost per gram skyrocketed after the vast majority of their cultivation labor was rounded up. I feel bad for those individuals, to be clear. GH should be under a microscope but in this administration it was probably a one-and-done show of ICE force. So maybe their costs do come back down. Read the transcript from the last quarter, if you think I'm ranting. They talk in their scripted remarks about the challenges replacing cultivation labor with 5 years of experience vs. new hires with 5 months of experience. That indicates this has been part of their model for a long time. I'm sure you know the reason illegal labor is used is because it's significantly cheaper than legal labor. They don't talk about that explicitly for obvious reasons. Over 360 individuals were captured by ICE. That's is approximately the entire team at Glasshouse. And anyone who knows cannabis cultivation knows it's not rocket science that needs years of experience to master if there is a solid system in place. If you don't own the stock it's even more bizarre you are here defending them and downvoting any dissenters. Maybe read their own management's statements about the realities of what last July meant for them. Going back to enjoying my weekend, good luck to ya bud
Most LPs are dog shit, but there are a handful of good ones and you underestimate the global opportunity for high quality Canadian operators. The US is living in a backwards framework ripe for disruption. Most likely none of these companies will survive interstate commerce, and given the 10x population, even the largest US MSO has a tiny fraction of the market share that Canadian companies have in their markets. For example GH is known in California, and Trulieve in Florida, but none of these companies are truly tapping the entire population of the US. There's enough market share to go around for decades to come.. Canadian players will also have their chance in the US.
I've been ushing watching this videos for a month now, but have fun : [50% Of Al Data Centers Have Quietly Been Cancelled Or "Delayed"](https://youtu.be/w-DVTHH1ux8?si=fC3kpV0UfgPrZ4GH) Ed Zitron, I know, he's a bear, but a bear invited on Bloomberg yesterday, that has investigated this very matter. Worth watching.
Don’t let the GH train pass you by. Up 194% over the past 12 months, 31% YTD and it’s just getting going.
Thanks for your comprehensive response. I hear ‘ya about the rich valuation relative to every other cannabis stock out there. Viridian capital markets had put out some relative valuation charts and GH was out in the stratosphere. But in my case, I was buying GH heavily for months on end back in the low $2’s (every penny I could spare actually) so I’m not complaining about the rich multiple. But making a first entry at this point -> would pass and focus aggressively on Trulieve if I wasn’t already in it.
Which positions are you holding as better operators? I’m betting big on GH but also have large positions in LEEF and Trulieve, moderate sized in GTII, and a smallish position in Verano/C21/Grown Rogue. How do you feel GH is being artificially propped up and by whom?
Plus the MSOs might get killed with some expensive write downs due to duplicity of operations once the walls of interstate commerce come down. Makes me think my MSO holdings might at best, end up being a trade while my GH position could remain a long term hold.
GH. Up 231% YTD. Only blood test for cancer approved by FDA and includes in ACS/NCCN guidelines.
GH. Up 7.5% today, 31% for the week. Just announced the American Cancer Society just endorsed their Shield product. It’s gonna run wild.
Honestly you retards are retarded. Today be like Oooh MU get me over the line one more time baby, whereas oil = hurr durr oil bols in shambles. I'm not going to tell you outright where you are going wrong but here's a clue: B*Y H*GH S*LL L*W Try working that one out. I'm putting 5% of my nw into oil tomorrow morning UK time. I might lose money but I will feel less of a twat than if I put it into MU
GH up 29% this week. 50% this month. 225% past 12 months. To the moon.
$GH AI assisted cancer diagnostics + simple blood draw is the future
I pay $200 for max 20x every month for my personal projects. I use opus/Sonnet via github copilot cli at work. GH Cli is excellent and I feel no downgrade.
GH. Announced FDA approval of ANOTHER liquid biopsy for cancer/tumor detection that wasn’t supposed to be approved until the fall. Revenue projections just went way up, and they were already consistently out performing each quarter. Stock up 17% today, 185% over the past year. LFG!
extreme overpay for EXAS. $GH will dominate that field $BSX getting punished for overpaying for $PEN as well, market doesn’t like either acquisitions
I bought MU so it’s going to tank now. GH BOIS
I’ll second that on Glass House. I’ve got large positions in Green Thumb and Trulieve too but think in the long term, the cost of duplicity of operations may saddle them and become GH’s competitive advantage. That’s why I’m thinking GH as a long term hold and GTI/Trul as a medium term trade. As a runner up conviction play, I’ve built a good sized position in LEEF which I feel will follow in GH’s shadow but maybe lag by a year or two as they continue to ramp up operations and drive costs down. Only difference being theirs is a target niche market for concentrates.
Yes! GH Copilot. Will just be a matter of time with rest if they begin to feel squeeze of revenue because it’s not growing fast enough. They will be able to charge whatever they want, because a usage based model obscures how much you are actually paying
CMPS got to Phase 3 first but “further along” isn’t “better positioned.” The killer issue is treatment duration. CMPS psilocybin requires 4-6 hours of supervised clinic time. GHRS GH001 takes ~11 minutes, discharge-ready within 1 hour. That’s 8-10 patients per chair per day vs 2. Payers and clinic operators will do that math real fast. The data also isn’t close. GH001 Phase 2b showed -15.5 point MADRS reduction vs placebo with 57.5% remission at Day 8 and zero serious adverse events. CMPS COMP360 had fading efficacy by week 12 and suicidal ideation flags. GHRS published in JAMA Psychiatry. Sell-side: 9/9 Buy on GHRS, 14/14 Buy on ATAI. CMPS consensus is mixed. I’d rather own the best data entering Phase 3 than the worst data already in Phase 3.
down 8% ytd but up 140% in the last year because my portfolio is 100% allocated to GH
I'm using GH Copilot for a legacy software project. Gemini doing fine, Claude doing quite well, GPT doing stupid things. That isn't Codex, though.
Iran is the first and only country to shoot down F-35s in combat. I'm not even talking about today. They shot down two of them last year during the Twelve Day War. They are impressive jets, but they are just airplanes at the end of the day. https://www.msn.com/en-us/news/world/the-day-stealth-died-iran-becomes-first-country-to-destroy-f-35-jets-in-active-combat/ar-AA1GH44a
This sounds like a “grass is greener” perspective. My company is power user of GH, and it’s been nightmarish lately dealing with service outages across their offerings. It’s been rough for a couple years, but recently we experience a noticeable service outage daily at this point. I’d be a bit worried if I was GH/MS. IIRC, GH blames azure migration for the instability, but that doesn’t exactly instill confidence either, as azure has been the least polished, most prone to capacity issues, and general lack of polish/ux compared to GCP and AWS. I find it hard to believe GL won’t at least be able to compete from an agentic workflows standpoint, since integration is a matter of MCP/cli. Provided, I have not extensively used GL (especially in age of coding agents). Tbh, I’d be more wary of self-hosting gitea or something as a real competitor if reliability of these cloud services continues to be a significant issue.
Why tf do we spell that word with a GH in the middle of it anyways
i have all of my portfolio in a single stock (GH), i just find it amusing that the average redditor thinks they believe they can time and beat the market. and then are also advising others to do the same. pretty funny
"Strait" describes a narrow passage of water between two larger bodies of water. Straight with a GH has many other meanings.
you should buy GH! my highest conviction play right now, PT 200+
The post is contextually accurate. [](https://www.google.com/search?sca_esv=016f34706b28a015&rlz=1CAUSZT_enUS1009US1009&sxsrf=ANbL-n4PvnSa6PbOpEcc2aSt-54WSUCGOQ:1771964427665&q=contextually+definition&si=AL3DRZEf8ou_2THlnY5rB7rJLFrTywWKiesgJFLlCF_SIzLBD6EfCbc_pptZt2g1ii-XugFphkeZWANqwT8MJUkAe1UZUeo6-kG62c20SLjkCsZdw5FwqxL2M7mVrTmPIed5lJnHwHGEJDVsXxJKbTJK7kyID0YQ97GH1hV0FjpW0WqYVbFImfY%3D&sa=X&ved=2ahUKEwjf2I_y-fKSAxW2j4kEHcx8EfcQyNoBKAB6BAgYEAA&ictx=1)
Absolutely. There is no "tech debt", I have no idea where you get that from. Claude seems to even figure out what coding style is being used and mimics it. It even does code reviews for us on GH and is amazing and pointing out subtle flaws or large flaws.
90%+ software engineering work is stuff like "Ticket #1003918 - Investigate slowness in the billing report handler". You're very rarely building brand new things. The way my AI workflow using Claude models in GH Copilot IDE extension would be something like highlighting a function I suspect is the culprit, entering into the flyout chat panel in my IDE: > I think this function causes slowness during large report generation. Resource utilization (cpu seconds, memory, heap, threads) during the slowness is all normal. Do you see where the bottleneck might be? Then it think for 2 minutes and comes back with something like > This function calls another function XYZ in the data object class that has a misconfigured thread pool, because of setting ABC, during scondition DEF it processes query GHI serially instead of in parallel And then you fix the thing thats wrong. Another thing we use it for a lot is, we have some codebase with absolutely no documentation but we need to understand how it works; > Starting at main.cs crawl every function call and add a node to a mermaid chart for each function and call; annotate each node with the function's purpose A lot of our busy work is done this way now. Even using my IDE copilot chat to automatically handle the opening/transitioning/closing of ticket items as I commit work to git. MCP servers let you do a lot with the chat models from your IDE now so its kind of a nice bonus feature that it eliminates a lot of context switching.
Closed EPAM puts today, nice print... Opened today: - Calls: AXTI • AD • GH - Puts: TDS • DBX • FIVN • WK • SFM TDS is my favorite put for whatever that's worth, which isn't much... *Disclaimer: these are not recommendations and why would you listen to a guy on the intertubes anyway*
medical tech. $GH, $DXCM, $INSP, $TMDX
Gold up over 80% since Jan 20, 2025. One or two more rate cuts and increased spending this year and we'll likely see 6k. President is not the primary driver of rise, but definitely not helping. Swiss Francs are up 12+% in the same time frame which is A LOT for Francs. True bagholder was always going to be the winner of the 2024 election. GW Bush learned this in his second term. Like Hoover in '29 or GH Bush in '91.
$12!? I’d love to pay that. it’s like fucking $30 to get that shit delivered on GH, especially if you wanna tip.
Been a large position in LEEF for months now hoping the stock performance will follow GH’s trajectory. Had you seen yesterdays LEEF update: https://youtu.be/iR3pqQGANo4?si=SBVHiBlLAGurqzpm
One of these days AAPL calls have to pay off right? R I GH T??
After a 450% sprint, I quietly relieved $GH of some excess baggage ;) Took a modest toe-dip into $KRKNF.
always liked GH, been posting about it in many comments urging people to buy when it was 40
I see you made a post for DXCM. Is GH a new one you like?
oh i forgot to mention GH is a likely takeover target, just look at EXAS last month. Although, i have a feeling GH management would reject any bid as they know they can build the next 100b company
in short - GH will be the near monopoly in cancer screening few years from now and DXCM is comically undervalued 1 year price target
I commented in the last thread and was openly skeptical. I’ve got to give you credit, you nailed that one. Investing in health-related companies makes me nervous, but I’ll at least take a look at these two. Any thoughts on why you’re optimistic on GH and DXCM? Timeframes for your price targets?
IMO, RXRX is a very Cathie Wood stock. It conceptually sounds appealing/exciting theme but when you look at ARKG over the last 5 years, you can see the "hype years" and you can see the years where healthcare is struggling and fundamentals matter. In the latter (2021, 2022, 2024) , the fund has been at the bottom of the category. When you look at the long-term? 3YR/5YR/10YR the fund is at or near the bottom of the category. IMO, if you have one of the greatest growth investing periods that I've ever invested in and the 5 year chart is just a continual erosion, there's something amatter. Recursion merged with peer Exscientia in August 2024. If this was such a compelling area, why would that company sell itself way off the highs? The merger hasn't seemed to help RXRX either. In terms of trials: REC-994 (Cerebral Cavernous Malformation): Recursion's lead candidate failed to demonstrate convincing efficacy in Phase 2. While it met the primary goal of safety, long-term extension data showed no promising trends in MRI or functional outcomes, becoming indistinguishable from natural history. REC-2282 (Neurofibromatosis Type 2): Development was halted after preliminary Phase 2/3 data from the POPLAR-NF2 trial showed limited tumor shrinkage and clinical activity. While the 40mg dose passed a futility threshold, the totality of the data did not justify further investment. REC-3964 (C. difficile Infection): Despite being the first new chemical entity developed through the "RecursionOS" platform, this Phase 2 program was discontinued in May 2025. The company cited a strategic decision to focus on other areas rather than clinical setbacks. REC-4881 (Solid Tumors): A pause was announced for this drug specifically targeting solid tumors, though it remains in development for other indications like FAP (Familial Adenomatous Polyposis) where it has shown more positive results. The company has been around for a bit now and when you look at the pipeline, there is one thing in phase 2, nothing in phase 3, the rest are all phase 1/pre clinical. Looking at a discussion on r/biotech: "Think it came up in another thread, but they just don't give the vibe they know what they're doing in clinical development. It's hard to say it exactly. But somehow they don't talk like they understand how hard it is to actually get something to market and what needs to be done to make that happen." (https://www.reddit.com/r/biotech/comments/1f8icsi/with_few_specifics_recursion_underwhelms_with/ - another thread: https://www.reddit.com/r/biotech/comments/1klmsi1/what_do_you_guys_think_of_recursion/) Also, I wasn't even aware the CEO stepped down a couple mo ago. Again, not saying this is a zero and don't want to be harsh but I just think this is one of those things where the results haven't matched the hype. The stock is 33% short (which says something) so any good news and could get a short squeeze. There is some cash to get through the year and there is a pipeline, but nothing in that pipeline is in stage 3/is seeming to generate that much excitement. IMO, AI around genetic testing (TEM, GH, former ILMN spin off/source of controversy GRAL, NTRA) has been an investment theme that has delivered a lot more than AI drug discovery - at least at this point.
GH will double within a year. PT 200 I said it would double when it was 40 on this sub, look at it now
i opened a position in GH at 48 and doubled down at 35, now it’s 100. posted that it would double when it was 50 in this sub
GH will at least 5x within 5 years. they will be the monopoly in cancer screening for all cancers by then. i estimate 2030 sales to be 5.4b, they are currently at 902m ttm and CAGR has ticked up after the release of guardant shield (colon cancer screening, which has been historically underpenetrated in the cancer screening population due to patient reluctance to do colonoscopies) i posted about it here and other subs when it was 40. said it would be 100 within a year and it did
you can follow my posts, i post proof and always heavily invested in my plays https://www.reddit.com/r/stocks/s/2pzoapKwCd posted the above when PEN was 220, nearly 50% return in a month been posting about GH on this sub when it was 40, now 100 currently 200k in dxcm and GH, GH will go to 200 and dxcm at least 90
100% into GH, up 150% ytd this stock will hit 200 by end of next year
🤔 Could this mean then that VSCodes agent integrations with GH Copilot just stop? Enterprise seems to be using VSCode coupled with GH Copilot Enterprise.... unless swap to Cursor? I'm trying to make sense of "no one uses it..." the standalone Copilot enrrypoint ms branded is hot garbage compared to the UIs for Perplexity, OA, and Anthropic imho
Yup im sure you know lots of 16 year olds blasting test, GH, and Tren 🤡
Why every young retards look same? Stupid north face jacket, stupid broccoli hair, crocs and 16yrs old gym bros juicing like 300mg TST and GH? Like what is wrong with all these retards?
NBIS CRWV ASTS RKLB NVDA AVGO SMTC GH I hit the f\*cking jackpot ths year, a 56% return, I'm lucky as F\*ck
At least once a year I get a huge urge to play Guitar Hero for a day. And it's something I'd love to share with my young kids, but it's a huge pain in the ass to get a functioning setup with the guitar. I know the licensing must be hell, but I really wish they would slap a greatest hits collection or whatever on the marketplace and release a new version of the GH2/3 controller.
Anyone elsze got a problem where they get into a hobby, buy a bunch of cool shit for said hobby, and then lose interest in the hobby? Looking around this room: -Panasonic GH5/Olympus PEN EP-5/Olympus OM-D EM-10 MK III camera bodies and thousands in Micro Four-Thirds lenses: Haven't taken a picture that wasn't on my phone for over a year -Pioneer DDJ-400 mix controller with lifetime Rekordbox subscription & Minilab Arturia MIDI keyboard: Haven't touched them in 2 years and in a Japanese metal phase now -DJI Air 2S/Mini 3, Ronin RS3 gimbal w/ Raveneye upgrades: Never used the gimbal and haven't flown the drones in over a year, I think my license is expired -Dreamcast w/ GDEMU upgrades: Bought it to play Jet Set Radio, realized Jet Set Radio actually sucked and my childhood memories were from Xbox One's "Jet Set Radio Future" Bambu Lab P1S 3D printer: Haven't printed anything since Halloween It looks like a Silicon Valley pawn shop in here. I need to use this shit
GH. Up 82% in the past 3 months. Just got paid so adding more. Long play. 🚀 🌕
GH, CAI, NTRA, and countless pharma companies have similarly giant repositories of patient multiomic data. Not to mention the publicly available date made available through population sequencing programs.
# DO NOT IGNORE THIS COMMENT Hello R3TR0-GH02T, your comment has been removed because your account has low karma. We have this filter in place to help protect against bots, trolls, and spammers. We might approve your post if you were not spamming/trolling/etc in some time if your post is of significant quality. Please message the mods of r/shortsqueeze using [this link](https://reddit.com/message/compose/?to=/r/Shortsqueeze&subject=Content+Approval+Because+of+Low+Karma) if you believe this is in error and you DO fit the requirements. You will not be approved for telling us you are not a bot. (Please note -- It will not be approved sooner if you message us 5 minutes after it gets removed or if you message multiple times). Also, messaging us to say that you are not a bot is not qualification for this post to be approved. Please do not message us unless you have over the approved karma limit (25). If you do not know what karma is, or how to get it, check our r/newtoreddit *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/Shortsqueeze) if you have any questions or concerns.*
https://pbs.twimg.com/media/GH86DOpXoAAp9_9?format=jpg&name=medium
https://pbs.twimg.com/media/GH86DOpXoAAp9_9.jpg
Excluding ETFs, Google’s #2 for me. Shockingly, $GH (a biotech) is #1. Both had earnings today.
## Update: Took profits on several shortly after Party Pooper Powell blurted that he doesn't want us all making money this holiday season... Closed calls early for profit today: BBIO CHRW EL GH PBF LLY GOOG EBAY ALNY I recognize that these may be premature, but it was also done to reduced my exposure and risk going into tomorrow. I dumped a bunch of my long positions as well.
Then I maybe misread. If so, im sorry. Your whole answer was with quite a hard tone while I just wanted normal conversation about investing. Investing is something beautifull and nice to talk about. Thanks I will check in on GH. I hope you are wrong on MYNZ and i will earn some money with it! I hope you earn some money as well with your portfolio!
i really wasn't but i can't change what you think and sure, put your money in $GH. i'm all in, i've been posting it in my comment history since march
i really wasn't but i can't change what you think and sure, put your money in $GH. i'm all in https://www.reddit.com/r/stocks/comments/1ja80i2/what_are_you_guys_buying/mhjf6dc/
here i'll bite since you're pretty enthusiastic and haven't done much research MYNZ main product is coloalert, which is a direct competitor to Exact sciences' cologuard. both tests use stool samples, which you basically poop in a tube and ship it back for the company to analyze. ColoAlert is offered in europe while cologuard is offered in the US the thing is, while both tests are accurate, both will lose in the long-term to Guardant Health's blood draw because of one simple reason - no one wants to handle their own poop and would much rather take a blood draw at the expense of a little accuracy. on top of that, MYNZ is half a decade behind EXAS in the US, this type of product requires an extensive sales force to propel sales and an established distribution network - on top of that, they cannot compete against GH and EXAS which already have approved insurance reimbursements and partnerships with hospitals and private payer networks. this is a losing race for MYNZ i won't even talk about their financials. they are horrid. this product is selling like shit in europe. last fiscal year, only 500k in revenues and 19m in overhead to achieve that. the company spent 17m last year in operations and only has 6m cash in the bank left. they will copy the well known playbook around this sub where they constantly dilute and dilute shareholders and then do a reverse split so they can repeat the process until even the dumbest shareholders get tired of this cycle into eventual bankruptcy do not put your money into this shit (literal shit)
A good entry into Gerresheimer. The pharmaceutical packaging specialist also for Novo. GH is poised for a rebound.
 Can you make it even harder to read?
 Give em hell kiddo
You are using Unit economics and that was viable pre GB200 - Meaning, nobody was scaling NVLink because everyone wanted blackwell. GH200 could do it but that was like an iteration that was on wait for blacwell then go. Before that there was nothing really there worth noting. Look at the sales of H100's byoCPU and that of GH200's H100's were just the way in which people knew how to bring on GPU's for use. the game has totally shifted to GPU+CPU systems that can interconnect. That's net new in a very meaningful way.
i love a good dcf. i did one for tmdx when it was 60, and it hit my PT of 120 rather quickly. also did one for PEN at 180 and hit my PT of 300 i’ll post images later, not at computer but my latest play is GH at 40 with a DCF PT of 100
you can find similar trading patterns with every stock. from my experience, they work until they don't and a new pattern emerges or just devolves into complete randomness. two stocks that i've been long on, TMDX and GH, have had very predicable trading patterns on open for about a month each where they would gap up and then violently gap back down within the first 30 minutes. then suddenly, this pattern just stopped working there's no discernable reason as to why
GH also has two co ceos and are killing it recently
Surprised no one has brought up healthcare growth names yet…PINS and GH come up a lot in my own screens. Anyone else bullish on healthcare growth going into the back half of the year?
GH is an interesting call…the cancer screening angle gives it a huge TAM if adoption scales…The challenge I see is balancing that long term potential against how much runway the market has already priced in at $66…Do you see it as more of a decade-long compounder or a near-term trade based on momentum?
$GH ive posted multiple times in this sub and many comments about how it will be $100+ a year from now. posted when it was $40, now it’s $66. they will be the monopoly in cancer screening a decade from now
I’ve got a large position in GH and haven’t sold a single share since the raid. Interesting that the management dropped the libel lawsuit against Elliot when he went public with his allegations about backdooring. My take is they preferred to focus on growing the business rather than waste resources on a time consuming and perhaps expensive lawsuit. Perhaps there was also a concern about corporate cannabis trying to squash the little guy (David vs Goliath). I might be wrong but based on: - no management has departed after the raid to my knowledge - insiders participated heavily in the refi announced shortly after the raid - previous site inspection found no issues a few months earlier - CEO has said contract with labour suppliers stipulates that all migrant workers must be of age - company was paying 25% higher rates than the standard ag worker in Cali is getting paid (sounds like “exploitation” to me!!!) - no charges have been laid; just lots of accusations being thrown around - no suspension of their license to date by the licensing board (my understanding is having minors on site of a cannabis facility is grounds for immediate suspension) - Cohodes dropped another $3M invested into GH when the sold tanked after the raid. Marc has built a reportedly stellar career on shorting companies. He would be the first to know if there was corporate shenanigans at play. I believe if his research found foul play to be going on at hand, he would have no problem with dumping his shares and going short. Like Elliot, he has a loud voice and has no hesitation to use it. Given he and his son have millions of shares and are still long is reassuring to me. I might be blinded due to having a stake in the game, but from what I’ve seen, lots of accusations flying around here and on X but nothing substantiated to date. Time will tell.
In this market even shit tier stocks are up. What makes GH special ?
tired of the shilling of meme stocks here so i'll post an underrated gem $GH will be the monopoly in cancer screening for the most aggressive cancers 5 years from now. i've been posting about this stock on multiple subs since it was $30, it just breached $60 and will at least double from this point i've personally put 90% of my portfolio in this, basically a full port
Glass House got away with a crime. Don’t just blame ICE alone. GH is going to be bankrupt once lawyers figure out their ways to sue the hell out of them.
you're choosing the wrong healthcare stocks! medical tech is where it's at medtech is carrying my portfolio - TMDX, GH, ISRG, PODD, etc
grail is undoubtedly the leader in MCED tests but that's not even worth saying anything, there are huge concerns because they are extremely unreliable and have low sensitivities for early stage cancers GH already presented data for their MCED test and it is more favorable to galleri's for many types of cancers. galleri is not even close to getting any sort of regulatory medical reimbursement and revenue has been flat QoQ since they spun off from illumina. the test is not very useful at all
GH, been holding since 20s. they will be the monopoly in cancer screening a decade from now. will easily double within a year
KRKNF, GH, AUR, IAS, and obviously RKLB
LOL. My point is the truth. > Not efficiency Ah... speed and efficiency are one in the same. > an massive support team that will work with you directly? Jensen himself said that doesn't matter since the big customers write all their own software anyways. That was in response to a question of wouldn't it be a problem that GH breaks software compatibility with everything that came before. Jensen doesn't think it's a problem. Why do you?
Can you explain your reasoning behind GH and PT? I would like to why
put a significant port of your money into GH i posted about TNDM other subreddits when it was $4 in 2017 and told everyone to hold into a price target of $60. it reached $120. i 30xed my net worth on that one play and have since then consistently outperformed the market by investing solely in confident medtech plays [https://gyazo.com/9e31bfdf1caa5be69b13fa315cd9b423](https://gyazo.com/9e31bfdf1caa5be69b13fa315cd9b423) my most recent play i posted about on reddit was TMDX at 60 and it short squeezed all the way to $150 on stellar earnings. happy to provide proof if you want. my next double bagger is GH, PT of $100 within a year, could 4x within 3 years. they will have a near monopoly in cancer screening 5 years from now enjoy it if you trust the process
put a significant port of your money into GH i posted about TNDM other subreddits when it was $4 in 2017 and told everyone to hold into a price target of $60. it reached $120. i 30xed my net worth on that one play and have since then consistently outperformed the market by investing solely in confident medtech plays [https://imgur.com/a/uQ29jep](https://imgur.com/a/uQ29jep) my most recent play i posted about on reddit was TMDX at 60 and it short squeezed all the way to $150 on stellar earnings. happy to provide proof if you want. my next double bagger is GH, PT of $100 within a year, could 4x within 3 years. they will have a near monopoly in cancer screening 5 years from now enjoy it if you trust the process